Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Selling, General & Administrative
Adaptive Biotechnologies Corp
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Selling, General & Administrative
-$172.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Selling, General & Administrative
-$8.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Danaher Corp
NYSE:DHR
|
Selling, General & Administrative
-$13.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Selling, General & Administrative
-$904.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Agilent Technologies Inc
NYSE:A
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is Adaptive Biotechnologies Corp's Selling, General & Administrative?
Selling, General & Administrative
-172.5m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Selling, General & Administrative amounts to -172.5m USD.
What is Adaptive Biotechnologies Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-31%
Over the last year, the Selling, General & Administrative growth was 6%. The average annual Selling, General & Administrative growth rates for Adaptive Biotechnologies Corp have been -16% over the past three years , -31% over the past five years .